CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 23 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Ropivacaine 20 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04051684
NCT04051684Phase 2Completed
CompareCT.gov

Transverse Abdominal Plane Blocks for Bariatric Surgery Patients: A Single Blinded Randomized Controlled Study

Montefiore Medical Center·interventional·Posted Aug 9, 2019·Updated Dec 3, 2019

In Brief

A Phase 2 clinical trial evaluating Transverse abdominal plane block and Ropivacaine for Bariatric Surgery and Transverse Abdominal Plane Regional Blocks. Completed, enrolled 23 participants across 1 site.

Detailed Summary

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI \>35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBariatric Surgery, Transverse Abdominal Plane Regional Blocks
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 9, 2019
Enrollment StartApr 1, 2013
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.9 years ago

Interventions

Transverse abdominal plane blockprocedure

Regional anesthesia team will perform a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.

Ropivacainedrug

Regional anesthesia team will perform a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.